[Megaloblastic anemia secondary to pyrimethamine treatment].
D000328:Adult; D000748:Anemia, Macrocytic / Q000139:chemically induced*; D000749:Anemia, Megaloblastic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D011739:Pyrimethamine / Q000009:adverse effects*; D014123:Toxoplasmosis / Q000150:complications / Q000188:drug therapy
D011739:Pyrimethamine
Anemia megaloblástica secundaria a tratamiento con pirimetamina.